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Objectives/Hypothesis: To examine if macroscopic classification with a magnifying gastrointestinal endoscope with nar-
row band imaging (ME-NBI) is useful in predicting pathological depth of tumor invasion in laryngo-pharyngeal cancer.
Study Design: Retrospective study.
Methods: Preoperative endoscopy reports and postoperative pathological reports on 139 laryngo-pharyngeal cancer
lesions were retrospectively reviewed, and the association between macroscopic findings in the lesions and the depth of
tumor invasion was analyzed statistically.
Results: The ratios of lesions macroscopically classified as 0-I (superficial and protruding), 0-IIa (slightly elevated), 0-
IIb (true flat), 0-IIc (slightly depressed), and 0-III (superficial and excavated) in the preoperative endoscopy reports were 3%,
25%, 71%, 1%, and 0%, respectively. Regarding the depth of tumor invasion in the postoperative pathological reports, the
ratios of lesions classified as EP (carcinoma in situ), SEP (tumor invades subepithelial layer), and MP (tumor invades muscu-
laris propria) were 73%, 26%, and 1%, respectively. The ratios of subepithelial invasion or muscular invasion in 0-I, 0-IIa,
and 0-IIb were 100%, 54%, and 14%, respectively, and showed significant difference (P< 0.0001). Only one of 139 lesions
invaded the muscular propria.
Conclusions: This study is the first one to show that macroscopic findings by ME-NBI predict the depth of tumor inva-
sion in superficial laryngo-pharyngeal cancer. It was indicated that there is a little chance of muscular invasion if the lesion is
endoscopically diagnosed as 0-I or 0-II. A new T stage classification based on the depth of tumor invasion may be needed in
order to adapt the classification to include transoral surgery.
Key Words: Magnifying endoscopy, narrow band imaging, endoscopic laryngo-pharyngeal surgery, transoral robotic sur-
gery, TNM classification.
Level of Evidence: 4
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INTRODUCTION
Transoral surgery is a less invasive treatment that
is becoming a major strategy in the treatment for
laryngo-pharyngeal cancer. Since the 1990s, transoral
laser microsurgery (TLM) has been recognized as an
organ preservation strategy that reportedly has good
oncological control and functional results,1 although it
has not been widely used because of its technical diffi-
culty. Recently, transoral robotic surgery (TORS) is
becoming popular as a new treatment modality for
laryngo-pharyngeal cancer, and surgical robots are
widely used in the United States.1 To date, several meth-
ods have been reported as less invasive transoral surgi-
cal approaches, such as TLM, TORS,2–4 and transoral
videolaryngoscopic surgery.1 These surgical methods
have great advantages over the conventional open sur-
gery, especially in functional outcomes such as swallow-
ing and use of voice, and are creating a paradigm shift
in the treatment strategy for laryngo-pharyngeal cancer.
One of the most important factors for achieving suc-
cess in transoral surgery is the ability to determine
properly whether there is indication for transoral sur-
gery and especially the ability to estimate the depth of
tumor invasion precisely at the preoperative examina-
tion. Cancer lesions that invade bone or cartilage are
contraindications for this technique. In addition, the pre-
operative estimation of the depth of tumor invasion
strongly influences functional outcomes, such as swal-
lowing and use of voice, whereas the extent of resection
in the laryngo-pharynx directly affects swallowing and
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voice functions. Although computed tomography and
magnetic resonance imaging are widely accepted as use-
ful modalities for estimating the extent of tumor growth,
different preoperative invasion staging techniques may
help estimating the depth of tumor invasion more accu-
rately. Therefore, developing a method to predict the
depth of tumor invasion is needed in transoral surgery.
Narrow band imaging (NBI) is an innovative opti-
cal technology that can increase contrast of the precise
morphological changes in the mucosal surface. When
combined with magnifying endoscopy, NBI clearly visu-
alizes microvascular structures.5 In the head and neck
region, we have previously reported that magnifying
gastrointestinal endoscopy with NBI function (ME-NBI)
provides high-resolution images and is useful in detect-
ing early superficial laryngo-pharyngeal cancers, which
are difficult to detect by standard endoscopy.6–8 In addi-
tion to the detection, ME-NBI is useful in predicting the
depth of tumor invasion in the upper gastrointestinal
tract.9 For example, esophageal cancer is classified in
detail in terms of macroscopic morphology and the path-
ological depth of tumor invasion according to the Japa-
nese Classification of Esophageal Cancer (10th
edition),10 and correlations between endoscopic findings
and the depth of tumor invasion have been reported.11
Nevertheless, although Kikuchi et al.12 reported correla-
tion between microvascular characteristics and the
depth of tumor invasion in superficial pharyngeal can-
cer, no reports have been published regarding the corre-
lation between macroscopic findings and the depth of
tumor invasion in head and neck cancer.
Since 2007, the departments of otolaryngology head
and neck surgery and gastroenterology and hepatology in
our university hospital have been collaborating and have
been screening the laryngo-pharyngeal region of all
patients who have a history of esophageal cancer or head
and neck cancer by using ME-NBI. Detected lesions were
macroscopically classified and were then biopsied. If a
lesion was diagnosed as superficial cancer, it was treated
by either endoscopic submucosal dissection (ESD)13,14 or
endoscopic laryngo-pharyngeal surgery (ELPS), which was
developed to treat laryngo-pharyngeal superficial cancer.15
The purpose of this study is to examine if the preop-
erative macroscopic classification with ME-NBI is useful
in predicting pathological depth of tumor invasion in
laryngo-pharyngeal cancer. Endoscopic report data on the
screening and postoperative pathological results were ret-
rospectively reviewed, and the correlation between the
macroscopic endoscopic classification and the pathological
depth of tumor invasion was statistically analyzed.
MATERIALS AND METHODS
Patients and Lesions
During the period from February 2007 to January 2014, 176
consecutive laryngo-pharyngeal lesions in 106 patients were
treated with ELPS or ESD under general anesthesia at Kyoto
University Hospital, Japan. Among them, 139 fresh lesions of
carcinoma in situ or squamous cell carcinoma in 91 patients who
had no history of radiation therapy to the neck or surgery to the
same site are included in this study. The 15 patients excluded
from the study include four patients with a history of surgery on
the same site, four with a history of neck radiation, one with a
spindle cell carcinoma, and six with nonmalignant lesions.
Patients were predominantly male (86 cases, 95%) and the
median age was 67 years (range 33–85 years). Written informed
consent for the treatment was obtained from all patients; and
this study was approved by the institutional review board of
the Graduate School of Medicine, Kyoto University.
Macroscopic Classification by Magnifying
Endoscopy With Narrow Band Imaging
All procedures were performed using a ME-NBI (GIF
TYPE H260Z, Q240Z, or Q260J; Olympus Medical Systems,
Tokyo, Japan), as reported previously.5 In short, each patient
was sedated with 35-mg pethidine hydrochloride before the
examination. A nonmagnifying observation with NBI was per-
formed to identify abnormal mucosal areas. If abnormal muco-
sal areas (e.g., well demarcated brownish lesions) were
identified, photographs of the nonmagnified NBI view were
taken. Subsequently, the lesion and surrounding normal mucosa
was observed under magnification. ME-NBI has the capabilities
of both standard video endoscopy and adjustable image magnifi-
cation over a continuous range up to a magnification factor of
80, and it provides higher resolution images with higher
Fig. 1. The same superficial cancer lesion in the hypopharynx observed by endoscope for otolaryngology (ENF type VQ) with white light (A),
endoscope for otolaryngology (ENF type VQ) with NBI (B), and magnifying endoscope for upper gastrointestinal tract (GIF TYPE H260Z)
with NBI (C). (A) The lesion cannot be identified by ENT endoscope with white light. (B) The lesion can be identified by ENT endoscope with
NBI, although the contrast is poor. (C) The lesion is clearly identified as a brownish area with scattered dots of abnormal vessels, and the
margin of the lesion is easily traceable. ENT5ear, nose, and throat; NBI5 narrow band imaging.
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contrast compared to endoscopes with NBI used in otolaryngol-
ogy, such as ENF-VQ and ENF-VH (Olympus Medical Systems)
(Fig. 1).
If scattered brownish dots were observed within the lesion
under ME-NBI, the lesion was clinically diagnosed as malig-
nant, as has previously been reported for lesions in the esopha-
gus.16 Biopsy was performed to pathologically confirm the
malignancy after the observation.
Macroscopic morphology of the lesion was classified
quickly after the examination and reported in accordance with
both the Japanese Classification of Esophageal Cancer (10th
edition)10 and the General Rules for Clinical Studies on Head
and Neck Cancer (5th edition) of the Japan Society for Head
and Neck Cancer17 by at least two experienced gastroenterolo-
gists who had no information regarding the pathology. Accord-
ing to the Japanese Classification of Esophageal Cancer (10th
edition),10 superficial cancer is defined as a lesion with no inva-
sion to the muscularis propria, and tumors in which invasion is
diagnosed to extend to the muscularis propria or beyond are
classified as advanced type. The superficial type has the prefix
0 and is classified into 0-I (superficial and protruding type), 0-II
(superficial and flat type), or 0-III (superficial and excavated
type). Type 0-II (superficial and flat type) is classified into 0-IIa
(slightly elevated type: less than 1 mm in height), 0-IIb (true
flat type), and 0-IIc (slightly depressed type). The utility and
clinical relevance of the Japanese endoscopic classification of
superficial neoplastic lesions of the gastrointestinal (GI) tract,
including esophagus, stomach, and colon, were explored by an
international group of endoscopists, surgeons, and pathologists
in an intensive workshop in Paris in 2002, and the results9
were published in 2003. This endoscopic classification of the GI
tract is globally accepted and is also called the Paris endoscopic
classification.9 Clinically, the height and depth of a lesion are
evaluated by placing a single cup of the opened biopsy forceps
(approximately 1.2 mm in height) next to the lesion as a cali-
brating gauge. Lesions protruding above the level of the cup are
classified as 0-I; and protruding lesions that have a thick pedi-
cle with a broad base18 and restricted mobility are classified as
type 1, an invasive tumor. Lesions that are depressed by more
than half the level of a single cup are classified as 0-III.
Entirely flat lesions with neither protrusion nor depression
observed with ME-NBI are classified as 0-IIb. The 0-IIb lesions
are detectable only with NBI. This classification has been
applied for head and neck cancer by the Japan Society for Head
and Neck Cancer as the General Rules for Clinical Studies on
Head and Neck Cancer (5th edition).17 Schema views of each of
the subtypes of the superficial cancer are shown in Figure 2.
Surgical Procedure
If the lesion was clinically diagnosed as superficial cancer,
ELPS or ESD was indicated as a minimally invasive treatment
under general anesthesia. ELPS was developed to treat laryngo-
pharyngeal superficial cancer. The concept of ELPS is the same
as that of ESD in that both are performed as en bloc resection of a
cancer lesion following submucosal injection, but it differs from
ESD in that the resection procedure is performed by a head and
neck surgeon with both hands (Supp. Fig. S1). After starting the
use of ELPS in August 2009, all lesions have generally been
treated with ELPS except those that invaded the cervical esopha-
gus beyond the entrance of the esophagus. In brief, a curved rigid
laryngoscope (Nagashima Medical Instruments Company, Ltd,
Tokyo, Japan) was inserted to provide a working space in the
pharyngeal lumen, and a ME-NBI was inserted transorally by a
gastroenterologist to visualize the surgical field (Supp. Fig. S2).
The extent of the lesion and the exact margins were determined
by NBI and iodine staining. A mixed solution of epinephrine
(0.02 mg/mL) and saline was injected into the subepithelial layer
beneath the lesion in order to lift the lesion above the surround-
ing mucosa and to create a safety space. Specially designed
curved forceps13 (Nagashima Medical Instruments Company,
Ltd, Tokyo, Japan) and a curved electrosurgical needle knife
(Olympus Medical Systems) were orally inserted and the tumor
was resected. Thirty-five lesions were treated with ESD, and 104
lesions were treated with ELPS in this study.
Pathology and Evaluation of the Invasion of the
Tumor
All resected specimens were cut into longitudinal slices
2 mm in width after fixation. The slices were embedded in par-
affin and stained with hematoxylin-eosin. All specimens were
microscopically evaluated according to the World Health Orga-
nization Classification. T staging was performed according to
the Union for International Cancer Control tumor-node-
Fig. 2. Schematic view of the macroscopic classification of superfi-
cial esophageal cancer in the Japan Classification of Esophageal
Cancer (10th edition), modified from reference 10. This classification
is applied for head and neck cancer in the General Rules for Clinical
Studies on Head and Neck Cancer (5th edition) of the Japan Society
for Head and Neck Cancer17 and used for this study. 0-I (superficial
and protruding type: more than 1 mm in height), 0-IIa (slightly ele-
vated type: less than 1 mm in height), 0-IIb (flat type), 0-IIc (slightly
depressed type: less than 0.5 mm in depth), 0-III (superficial and
excavated type).
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metastasis (UICC/TNM) classification (7th edition) of the head
and neck cancer.19
Evaluation of the invasion of the tumor was also made
according to the General Rules for Clinical Studies of Head and
Neck Cancer (5th edition) by the Japan Society for Head and
Neck Cancer17 and the Japanese Classification of Esophageal
Cancer by the Japan Esophageal Society (10th edition).10
In the esophageal cancer, superficial cancers are pathologi-
cally classified as EP (carcinoma in situ), LPM (tumor invades
lamina propria mucosa), MM (tumor invades muscularis
mucosa), and tumor invades submucosa (T1b), depending on the
depth of tumor invasion.10 In the laryngo-pharynx, because mus-
cularis mucosa is absent in the laryngo-pharynx, the lesion was
classified into EP (carcinoma in situ), SEP (tumor invades sube-
pithelial layer) and MP (tumor invades muscularis propria),
according to the General Rules for Clinical Studies on Head and
Neck Cancer by the Japan Society for Head and Neck Cancer
(5th edition).17 In this study, all lesions were classified as EP,
SEP, or MP in accordance with the rule by the Japan Society for
Head and Neck Cancer.17 Schematic views of pathological classi-
fication of the depth of tumor invasion in the esophageal cancer
and head and neck cancer are shown in Figure 3.
Data Analysis
Macroscopic classification with a ME-NBI, pathological
classification regarding the depth of tumor invasion, lymphatic
invasion, vessel invasion, and recurrence was reviewed. The
association between macroscopic classification (0-I /0-IIa/0-IIb)
and the depth of tumor invasion (EP/SEP1MP) was statisti-
cally analyzed using the Cochran–Mantel–Haenszel test (degree
of freedom5 1). Because of the small sample size (N5 1), 0-IIc
was excluded from the statistical analysis. SAS for Windows 9.3
(SAS Institute Inc., Cary, NC) was used for the analysis.
RESULTS
Lesion characteristics are shown in Table I. Of the
139 lesions resected, the total number of lesions in the
oropharynx, hypopharynx, and larynx was 41 (30%), 95
(68%), and three (2%), respectively. In the oropharynx,
the numbers of lesions in the anterior, posterior, supe-
rior, and lateral walls were five (12%), 19 (46%), nine
(22%), and eight (20%), respectively. In the hypophar-
ynx, the numbers of lesions in the piriform sinus, post-
cricoid, and posterior walls were 76 (80%), three (3%),
and 16 (17%), respectively. In the larynx, all lesions
were in the supraglottic area. Regarding the T classifica-
tion, 101 lesions were pathologically diagnosed as Tis, 16
lesions as T1, 18 lesions as T2, and four lesions as T3.
Macroscopic classification, pathological classifica-
tion regarding the depth of tumor invasion, lymphatic
invasion, vessel invasion, and the number of recurrences
are shown in Table II. The numbers of lesions classified
macroscopically as 0-I, 0-IIa, 0-IIb, 0-IIc, and 0-III were
4 (3%), 35 (25%), 99 (71%), one (1%), and 0(0%), respec-
tively. Representative images of each subtype are shown
in Figure 4. Regarding the depth of tumor invasion, the
numbers of lesion classified as EP, SEP, and MP were
101 (73%), 37 (26%), and one (1%), respectively.
In the 0-I lesions, all lesions showed subepithelial inva-
sion (SEP). In the 0-IIa lesions, 18 lesions (51%) were SEP;
Fig. 3. Schematic view of the pathological classification for the superficial cancer of the esophageal cancer and the head and neck cancer,
in the Japan Classification of Esophageal Cancer (10th edition)10 and the General Rules for Clinical Studies on Head and Neck Cancer (5th
edition) of the Japan Society for Head and Neck Cancer,17 respectively, modified from reference 10.
In the esophageal cancer, superficial cancers are classified as EP (carcinoma in situ), LPM (tumor invades lamina propria mucosa), MM
(tumor invades muscularis mucosa), and tumor invades submucosa (T1b), depending on the depth of tumor invasion. In the laryngo-
pharynx, because muscularis mucosa is absent in the laryngo-pharynx, the lesion was classified as EP (carcinoma in situ), SEP (tumor
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one lesion (3%) was MP; and vessel invasion was observed
in three lesions (9%). In the 0-IIb lesions, most lesions (86%)
were EP and there was no vessel invasion. Only one lesion
was classified as 0-IIc; and the lesion was pathologically
classified as SEP with lymphatic duct invasion.
The ratios of subepithelial invasion or muscular
invasion (SEP1MP) in 0-I, 0-IIa, and 0-IIb were 100%,
54%, and 14%, respectively, and showed significant dif-
ference (P< 0.0001).
DISCUSSION
The present study showed strong correlation
between macroscopic classification by ME-NBI and path-
ological depth of tumor invasion. This is the first report
to show that macroscopic findings by ME-NBI predict
the depth of tumor invasion in superficial laryngo-
pharyngeal cancer.
Correlations between endoscopic macroscopic type
and invasion depth have been reported for superficial
esophageal squamous cell carcinoma and early gastric
and early colorectal adenocarcinomas in the Paris endo-
scopic classification,9 which was made based on the Jap-
anese endoscopic classification of superficial neoplastic
lesions of the GI tract. In the multicenter analysis of
superficial esophageal squamous cell carcinoma con-
ducted in Japan on the basis of 2,418 patients from 143
institutions,20 the total risk for submucosal invasion is
high (90%) in type 0-I lesions. The highest risk occurs in
type 0-I and in type 0-III lesions, and the lowest risk is
in type 0-IIb lesions. Ratios of invasion deeper than EP
in 0-I, 0-IIa, 0-IIb, and 0-IIc were 99% (259/262), 89%
(270/303), 47% (104/221), and 80% (567/707), respec-
tively. In our study, the highest risk for subepithelial
invasion occurred in type 0-I (100%); and the lowest risk
was in type 0-IIb lesions (14%), which were similar to
the results in esophageal cancer.
The major difference between our study and the
report on esophageal cancer is the overall ratio of submu-
cosal (muscularis propria) invasion in 0-I and 0-II lesions.
The overall ratio of invasion to muscularis propria in 0-I
and 0-II lesions in our study was only one of 139 lesions,
whereas it was 52% in esophageal cancer.20 We suggest
that one reason for this discrepancy may be associated
with the different populations. For example, in our study
there was just one 0-IIc lesion, but the ratio of 0-IIc in
esophageal cancer was 47%. Although it is unclear if the
population difference is due to a natural characteristic of
laryngo-pharyngeal cancer or to an institutional bias, the
results indicate that there is a little chance of muscular
invasion in the laryngo-pharyngeal cancer as long as the
lesions are diagnosed as 0-I and 0-II.
Finally, the correlation between macroscopic mor-
phological classification and the depth of tumor invasion
shown in this study may contribute to modify the T
stage classification in head and neck cancer. The T stage
classification of head and neck cancer, especially in the
pharynx, is based on the diameter of the tumor. This is
probably because radiotherapy or open neck surgery are
two standard modalities, and the volume or the area of
the tumor are important for them. The T staging system
is the gold standard in evaluating a primary lesion and
its prognostic importance is widely accepted. However,
the limitation of the current T staging system is becom-
ing evident with the development of new treatments and
diagnostic modalities. For example, NBI enables detec-
tion of superficial pharyngeal cancer lesions that are
barely visible by conventional methods, and excellent
long-term oncological outcome for endoscopic resection of
such lesions is reported with the 5-year cause-specific
survival rate of 97%.13 According to the current T stag-
ing system, a pharyngeal superficial cancer with micro
invasion, such as SEP, is diagnosed as T3 when it is
TABLE II.
Macroscopic Classification by Magnifying Endoscope, Pathological Classification Regarding the Depth of Tumor Invasion,




Depth of Tumor Invasion
EP SEP MP ‘y (1) v (1)
0-I 4 0 4 0 0 0
0-IIa 35 16 18 1 2 1
0-IIb 99 85 14 0 0 0
0-IIc 1 0 1 0 1 0
0-III 0 0 0 0 0 0




*The ratios of SEP1MP in 0-I, 0-IIa, and 0-IIb showed significant difference (P< 0.0001; Cochran–Mantel–Haenszel test: degree of freedom5 1).
Laryngoscope 125: May 2015 Tateya et al.: ME-NBI to Predict Invasion in Laryngo-Pharyngeal Cancer
1128
more than 4 cm in diameter or when it invades to the
entrance of the esophagus, although it is a superficial
lesion with excellent prognosis. In esophageal cancer,
transoral endoscopic resection is a standard treatment,
and T stage classification is based on the depth of tumor
invasion because the depth is an important factor in
determining whether there is indication for endoscopic
treatment. Indeed, in esophageal cancer,10 EP, LPM, and
MM lesions are classified as T1a; a SM lesion is classi-
fied as T1b; and a lesion with invasion to the muscularis
propria is classified as T2. Faced with the paradigm
shift in treatment modality from open surgery to trans-
oral surgery, it may be necessary to adapt a change in T
stage modification based on the depth of tumor invasion
in the laryngo-pharyngeal cancer. The findings shown in
this study will help to develop the new T stage classifica-
tion based on the depth of tumor invasion.
There are two limitations in this study. One is the
small number of invasive lesions. There was no 0-III
lesion in the study because 0-III lesions were primarily
treated with radiation or concurrent chemoradiotherapy,
and pathological information other than biopsy results
was not obtained. The other limitation is that the study
was a retrospective study. A prospective, randomized,
controlled multi-institutional trial should be conducted
in the future to validate the results.
CONCLUSION
This study is the first to show that macroscopic find-
ings by ME-NBI predict the depth of tumor invasion in
superficial laryngo-pharyngeal cancer. The highest risk
for subepithelial invasion was present in type 0-I (100%),
and the lowest risk was in type 0-IIb lesions (14%). Only
one out of 139 lesions of 0-I and 0-II invaded muscular
propria; and it was indicated that there is a little chance
of muscular invasion in the laryngo-pharyngeal cancer as
long as the lesions are diagnosed as 0-I and 0-II.
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